Table 2.
General characteristics of individual studies on prophylactic antifungal therapy using a single-drug antifungal prophylaxis regimen
Reference | Year | Country | Inclusion period | Study design |
Slotman and Burchard [65] | 1987 | USA | October 1982 to July 1985 | RCT |
Savino et al. [25] | 1994 | USA | July 1990 to December 1991 | RCT |
Eggimann et al. [4] | 1999 | Switzerland | Not specified | RCT |
Ables et al. [66] | 2000 | USA | October 1994 to December 1996 | RCT |
Pelz et al. [67] | 2001 | USA | January 1998 to January 1999 | RCT |
Sandven et al. [6] | 2002 | Norway | March 1994 to June 1995 | RCT |
Garbino et al. [68] | 2002 | Switzerland | 30 months | RCT |
He et al. [69] | 2003 | China | January 1998 to December 2002 | RCT |
Jacobs et al. [70] | 2003 | Saudi Arabia | December 1998 to June 2001 | RCT |
Piarroux et al. [38] | 2004 | France | August 1998 to July 2000 | Intervention study |
Normand et al. [24] | 2005 | France | February 2002 to July 2002 | RCT |
RCT, randomised controlled trial.